GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (NYSE:LLY) » Definitions » Dividend Yield %

Eli Lilly and Co (Eli Lilly and Co) Dividend Yield %

: 0.62% (As of Today)
View and export this data going back to 1970. Start your Free Trial

As of today (2024-04-17), the Trailing Annual Dividend Yield of Eli Lilly and Co is 0.62%.

Warning Sign:

Eli Lilly and Co stock dividend yield is close to 10-year low.

The historical rank and industry rank for Eli Lilly and Co's Dividend Yield % or its related term are showing as below:

LLY' s Dividend Yield % Range Over the Past 10 Years
Min: 0.58   Med: 2.2   Max: 4.05
Current: 0.62

During the past 13 years, the highest Dividend Yield of Eli Lilly and Co was 4.05%. The lowest was 0.58%. And the median was 2.20%.

LLY's Dividend Yield % is ranked worse than
84.34% of 498 companies
in the Drug Manufacturers industry
Industry Median: 1.775 vs LLY: 0.62

Eli Lilly and Co's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.45.

During the past 13 years, the highest Dividend Payout Ratio of Eli Lilly and Co was 1.96. The lowest was 0.45. And the median was 0.56.

As of today (2024-04-17), the Forward Dividend Yield % of Eli Lilly and Co is 0.70%.

Eli Lilly and Co's Dividends per Share for the three months ended in Dec. 2023 was $1.13.

During the past 12 months, Eli Lilly and Co's average Dividends Per Share Growth Rate was 15.30% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 15.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 15.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 9.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Eli Lilly and Co was 20.20% per year. The lowest was 0.70% per year. And the median was 7.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Eli Lilly and Co Dividend Yield % Historical Data

The historical data trend for Eli Lilly and Co's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Yield %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.96 1.75 1.23 1.07 0.78

Eli Lilly and Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Dividend Yield % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 1.19 0.90 0.81 0.78

Competitive Comparison

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co Dividend Yield % Distribution

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Dividend Yield % falls into.



Eli Lilly and Co Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Eli Lilly and Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 1.3002024-02-142024-02-152024-03-08Cash DividendquarterlyUSD:USD 1.000000
USD 1.1302023-11-142023-11-152023-12-08Cash DividendquarterlyUSD:USD 1.000000
USD 1.1302023-08-142023-08-152023-09-08Cash DividendquarterlyUSD:USD 1.000000
USD 1.1302023-05-122023-05-152023-06-09Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Eli Lilly and Co's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=4.69/750.77
=0.62 %

Current Share Price is $750.77.
Eli Lilly and Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is $4.69.

Eli Lilly and Co's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=5.2/750.77
=0.69 %

Current Share Price is $750.77.
Eli Lilly and Co's Dividends per Share for the forward twelve months is calculated as $1.3 * 4 = $5.2.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eli Lilly and Co  (NYSE:LLY) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Eli Lilly and Co Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co (Eli Lilly and Co) Business Description

Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
Executives
Lilly Endowment Inc 10 percent owner 2801 NORTH MERIDIAN ST, INDIANAPOLIS IN 46208
Donald A Zakrowski officer: Chief Accounting Officer LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Alonzo Weems officer: SVP, ERM & CECO LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Patrik Jonsson officer: SVP and Pres., Lilly Bio-Meds LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Anne E. White officer: SVP & Pres-Lilly Oncology LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Eric Dozier officer: EVP, HR & Diversity LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Jackson P Tai director
Mary Lynne Hedley director C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Marschall S Runge director LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Naarden Jacob Van officer: SVP, CEO LoxoONC, Pres LlyONC C/O ELI LILLY & CO, LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Diogo Rau officer: SVP & CIDO LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Edgardo Hernandez officer: SVP & Pres., Mfg. Operations LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Kimberly H Johnson director C/O FANNIE MAE, 1100 15TH STREET, NW, WASHINGTON DC 20005
Anat Ashkenazi officer: SVP & CFO LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Gabrielle Sulzberger director 450 LEXINGTON AVENUE, FLOOR 13, NEW YORK NY 10017

Eli Lilly and Co (Eli Lilly and Co) Headlines